Search

everythinglearnresearchcommunity

for

Search:↓

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Endocrine disorders can cause various skin and hair issues.

Skin issues can indicate immune system problems.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.

Children's skin diseases and treatments differ from adults and require specific approaches.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Brunsting-Perry pemphigoid can cause scarring hair loss and may be underdiagnosed.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.